Immunome
IMNM
IMNM
113 hedge funds and large institutions have $578M invested in Immunome in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
13.67% more ownership
Funds ownership: 66% → 79.67% (+14%)
9% more funds holding
Funds holding: 104 → 113 (+9)
36% less capital invested
Capital invested by funds: $907M → $578M (-$329M)
Holders
113
Holding in Top 10
2
Calls
$1.2M
Puts
$882K
Top Buyers
| 1 | +$35.5M | |
| 2 | +$28.6M | |
| 3 | +$26.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$19.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$14.4M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$14.7M | |
| 3 | -$11.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.25M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.78M |